For more information regarding Bristol-Myers Squibb Clinical Trial participation, please
visit www.BMSStudyConnect.com
Inclusion Criteria:
a. For participants with plaque psoriasis: i. Stable plaque psoriasis for at least 6 months
ii. Moderate to severe disease iii. Candidate for phototherapy or systemic therapy b.
Additional protocol-specified inclusion criteria apply for subjects with psoriatic arthritis, erythrodermic psoriasis, or generalized pustular psoriasis
Exclusion Criteria:
  1. Guttate, inverse, or drug-induced psoriasis at Screening or Baseline
  2. History of recent infection
  3. Prior exposure to BMS-986165 Other protocol defined inclusion/exclusion criteria could apply
